Suicide Prevention Interventions for Autism
Trial Summary
What is the purpose of this trial?
This trial is testing two methods to prevent suicide in autistic youth aged 12-24. One method involves creating a personalized safety plan, while the other adds ongoing support through periodic check-ins. The safety plan helps individuals recognize warning signs and use coping strategies, and the check-ins provide continuous support.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Safety Planning Intervention tailored for Autistic Individuals (SPI-A) for suicide prevention?
The Autism Adapted Safety Plan (AASP), which is similar to SPI-A, is being tested for its feasibility and acceptability in autistic adults, indicating a focus on tailoring safety plans for this group. Additionally, clinicians report using safety planning as a suicide prevention strategy across different groups, suggesting its general applicability.12345
Is the Safety Planning Intervention for Autistic Individuals safe for humans?
How is the Safety Planning Intervention tailored for Autistic Individuals different from other treatments for suicide prevention?
This treatment is unique because it is specifically designed for autistic individuals, addressing their specific needs and challenges, unlike general safety plans which are not tailored for autism. It includes structured follow-up contacts to ensure ongoing support, which is not typically part of standard safety planning interventions.138910
Research Team
Danielle Roubinov, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Shari Jager-Hyman, PhD
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for young people aged 15-24 with autism who have had suicidal thoughts or behaviors. They must speak English and have received a safety plan tailored for autistic youth during a clinical visit. Those over 18 can consent themselves, while those under need parental consent.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Safety Planning Intervention tailored for Autistic individuals (SPI-A) or SPI-A plus structured follow-up contacts (SPI-A+)
Follow-up
Participants are monitored for changes in suicidal ideation, behavior, and other mental health outcomes
Treatment Details
Interventions
- Safety Planning Intervention tailored for Autistic Individuals
- Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Seattle Children's Hospital
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
University of Pennsylvania
Collaborator
Nationwide Children's Hospital
Collaborator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Collaborator
Children's Hospital of Philadelphia
Collaborator